SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadline - CVS - InsuranceNewsNet

Get the magazine read by the nation’s top 1% of producers delivered to your door monthly. Subscribe Now

InsuranceNewsNet

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading newswires
Topics
  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property & Casualty
  • Advisor News
  • Washington Wire
  • Sponsored Content
  • INN Exclusives
  • Newswires
  • INNsider
  • INN Exclusives
  • NewsWires
  • Magazine
Sign in or register to be an INNsider.
  • INN Exclusives
  • NewsWires
  • ★ Regulation News
  • Magazine
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Susbcribe

Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Insider
newswires
newswires RSS Get our newsletter
Order Prints Share
April 10, 2019 newswires No comments Views: 25

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadline – CVS

PR Newswire

NEW YORK, April 9, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS) and certain of its officers and directors.   The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01725, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates,  who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased CVS securities during the Class Period, you have until April 26, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

CVS Health was founded in 1892 and is headquartered in Woonsocket, Rhode Island.  The Company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014.  CVS Health, together with its subsidiaries, provides integrated pharmacy health care services, operating through its Pharmacy Services and Retail/LTC segments. 

On May 20, 2015, CVS Pharmacy, Inc. ("CVS Pharmacy"), a wholly owned subsidiary of CVS Health, entered into an Agreement and Plan of Merger (the "Merger Agreement") to acquire Omnicare, Inc. ("Omnicare"), a provider of pharmaceuticals and related pharmacy services to long-term care facilities and provider of specialty pharmacy and commercialization services for the bio-pharmaceutical industry (the "Omnicare Acquisition").  According to CVS Health's SEC filings, upon the effective date of the Omnicare Acquisition, each share of common stock, par value $1.00 per share, of Omnicare would be converted into the right to receive $98.00 in cash, or approximately $10.6 billion in the aggregate.  In addition, CVS Pharmacy would assume approximately $2.3 billion in debt of Omnicare.

On August 18, 2015, CVS Health acquired 100% of the outstanding common shares and voting interests of Omnicare for $98 per share for a total of $9.6 billion and assumed long-term debt with a fair value of approximately $3.1 billion.  Additionally, holders of Omnicare restricted stock units and performance based restricted stock units received 738,765 CVS Health restricted stock awards with a fair value of approximately $80 million as replacement awards.  According to CVS Health's SEC filings, the Company acquired Omnicare to expand its operations in dispensing prescription drugs to assisted-living and long-term care facilities, and to broaden its presence in the specialty pharmacy business as it sought to serve a greater percentage of the growing senior patient population in the United States.

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) CVS Health's financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health's public statements were materially false and misleading at all relevant times.

On February 20, 2019, CVS Health announced the Company's fourth quarter and full year financial and operating results and provided 2019 full year guidance.  CVS Health advised investors that adjusted earnings in 2019 would be $6.68 to $6.88 per share, compared with the $7.36 average of market estimates, citing rising costs and poor results related to the Company's 2015 acquisition of Omnicare. 

Following this news, CVS Health's stock price fell by $5.66 per share, or slightly over 8%, to close at $64.22 per share on February 20, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. WilloughbyPomerantz LLP
[email protected]
888-476-6529 ext. 9980

Cision View original content:http://www.prnewswire.com/news-releases/shareholder-alert--pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-cvs-health-corporation-of-class-action-lawsuit-and-upcoming-deadline--cvs-300829485.html

SOURCE Pomerantz LLP

Older

Billion-dollar Medicare fraud ring investigation started in South Carolina, feds say

Newer

WVU public health expert warns Congress of danger from mountain top mining

Advisor News

  • Vanguard: Expect 2020 U.S. Economic Growth To Tail Off
  • Rep. Waters: House Passes Financial Services Bill Banning Insider Trading
  • Citi Outlook 2020: Global Growth Can Endure Over The Coming Year
  • LPL Financial Launches No-Transaction-Fee, Exchange-Traded Fund Network
  • 16 Year-End Financial Planning Tips From The AICPA
More Advisor News

Annuity News

  • Robert Kerzner Joins PHP Agency’s Board Of Directors
  • Patriot Life Insurance Co. Boosts Life & Annuities Underwriting Capabilities
  • Commentary: Ned Ryerson Is Just As Cool As Gordon Gekko
  • Industry, Consumer Reps Take Final Whack At NAIC Annuity Sales Rule
  • MassMutual Study Finds Employers Worried About Employees’ Financial Woes
More Annuity News

Health/Employee Benefits

  • Rising Prices Drive Up Health Spending, Even As Use Remains Steady
  • US Report: Prescription Drug Prices Down Slightly Last Year
  • Milliman Analysis: Corporate Pension Funding Rises By $15B In November
  • Poll: Most In U.S. Still Favor Private Healthcare, But Numbers Falling
  • Survey: Most Consumers Satisfied With Their Health Insurance
More Health/Employee Benefits

Life Insurance

  • Pacific Life Sells Aviation Capital Group To Tokyo Century Corp.
  • Robert Kerzner Joins PHP Agency’s Board Of Directors
  • Florida Man Convicted Of Murdering Wife For Life Insurance
  • LIMRA: 3Q Life Insurance Sales Driven By 7% Bump In IUL
  • Foresters Financial Updates Underwriting To Cover Pot Smokers
More Life Insurance

Featured Offers

Text Ads

Press ReleasesAll press releases

  • Brookstone Capital Management Expands Darryl Ronconi’s Role, Naming Him President and Chief Operating Officer
  • WoodmenLife Launches Unified Selling Experience for Agents with iPipeline
  • National Western Life Selects Equisoft to Accelerate its Growth Strategy
  • Peter M. Bakker Agency awarded first Insurance Agency Apprenticeship in the State of Connecticut
  • iPipeline’s New Global Website Features Extensive SSG Digital Platform Offering
Add your Press Release >

Topics

  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty News
  • Advisor News
  • Washington Wire
  • Regulation

Top Sections

  • INN Exclusives
  • INN Insider

Our Company

  • About
  • Editorial Staff
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter Google+
© 2019 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • Sitemap
  • AdvisorNews

Sign in with your INNsider Account

Not registered? Become an INNsider.